logo
Share SHARE
FONT-SIZE Plus   Neg

Pre-market Movers For April 4 (PSDV, SRPT, CPWR, LULU)

Gainers:

pSivida Corp. (PSDV: Quote) is surging 19 percent to $2.70. The company announced that it has signed a funded technology evaluation agreement with a global pharmaceutical company to evaluate its proprietary Durasert and Tethadur technologies for select products in ophthalmology.

Sarepta Therapeutics, Inc. (SRPT) is up 3 percent to $35.11.

Decliners:

Compuware Corp. (CPWR: Quote) ia falling nearly 4 percent to $11.58 as the company warned that its fourth quarter results would come in way below Wall Street view due to delays in closing a large number of deals. The company also lowered its fiscal year 2013 revenue and earnings outlook.

Lululemon Athletica Inc. (LULU: Quote) is down nearly 1 percent to $63.75. The company announced that its Chief Product Officer Sheree Waterson will be leaving effective April 15. Last month, the company recalled its signature black Luon fabric yoga pants and crops from stores, showrooms and online website due to fabric quality issues.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
In a thumbs up for the Iceland bond market, investors strongly oversubscribed to a bench-marked bond offering by Arion Bank, as the Nordic island country warms up to possible easy access to international credit. Arion Bank issued bonds for 300 million euros and received bids of more than 675 million euros from about 100 investors. The bonds are 3-year instruments with a fixed 3.125 percent coupon. Pacific Investment Management Co. LLC, better known as PIMCO, said investors pulled $8.6 billion from its Total Return Fund in February, the lowest amount of monthly outflow since departure of bond guru Bill Gross last year. The outflows for the month of February from Pimco's flagship fund dropped... Sony said it plans to release its virtual-reality headset next year, giving gamers something more to cheer about when using their playstation 4 console.
comments powered by Disqus
Follow RTT